Literature DB >> 24507057

The role of coronary calcium score in the risk assessment of liver transplant candidates.

N Kemmer1, J Case2, S Chandna2, G W Neff3.   

Abstract

BACKGROUND: Coronary artery disease (CAD) is a common cause of morbidity and mortality in liver transplant (LT) recipients. To date there is no consensus on the preferred screening tests to detect CAD in the pre-LT population. Therefore the aim of this study was to: 1) evaluate the utility of a noninvasive tool (cardiac computerized tomography [CT] scan); and 2) determine the prevalence of CAD in low-risk LT candidates.
METHODS: Using our transplant database we identified all LT candidates classified as low risk for CAD. All low-risk candidates underwent cardiac CT scan for coronary calcium score (CCS) estimation. Those with CCS >100 underwent coronary angiogram, and those with <100 underwent stress test and if stress test was positive then coronary angiography was performed. The Agatston calcium score was classified as: normal (0), mild (1-100), moderate (101-400), severe (401-1,000), or extensive (>1,000).
RESULTS: Eighty-five LT candidates were classified as low risk and underwent cardiac CT scan. The mean calcium score was 325 (range, 0-3,707). In our study cohort, 21% had normal CCS score, 43% mild, 13% moderate, 11% severe, and 12% extensive. A calcium score >400 was significantly associated with CAD on angiography (P = .02). Although male sex was significantly associated with the presence of CAD (P = .006), there was no correlation with age, ethnicity, liver diagnosis, or Model for End-Stage Liver Disease score.
CONCLUSIONS: Prevalence of asymptomatic CAD in this low-risk population is relatively high. Cardiac CT is well tolerated and is a useful noninvasive screening tool in LT candidates. Future studies to determine its utility as a prognostic tool after LT will be invaluable.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24507057     DOI: 10.1016/j.transproceed.2013.09.035

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  18 in total

Review 1.  PRO: Cardiac Catheterization Is the Optimal Strategy for Cardiovascular Risk Stratification in This Patient.

Authors:  Brett Sadowski; Tilak Baba; Amol S Rangnekar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 2.  CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient.

Authors:  Shravan Dave; Abbey Barnard; Michel Mendler
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

3.  Low yield of routine stress testing in patients awaiting liver transplantation.

Authors:  Cigdem Akincioglu; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2018-08-30       Impact factor: 5.952

Review 4.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Authors:  Kalindi Parikh; Andrew Appis; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-10-08       Impact factor: 5.952

5.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

Review 6.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

7.  Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation.

Authors:  Sabha Bhatti; Blanca Lizaola-Mayo; Mohammad Al-Shoha; Mauricio Garcia-Saenz-de-Sicilia; Fuad Habash; Karam Ayoub; Michael Karr; Zubair Ahmed; Daniel Borja-Cacho; Andres Duarte-Rojo
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

8.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

9.  The predictors of post-transplant coronary events among liver transplant recipients.

Authors:  Mohammad U Malik; Stuart D Russell; Aliaksei Pustavoitau; Matthews Chacko; Arif M Cosar; Carol B Thompson; Panagiotis Trilianos; Nabil N Dagher; Andrew M Cameron; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2016-06-16       Impact factor: 6.047

Review 10.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.